EW logo

Edwards Lifesciences (EW) Cash From Operations

Annual CFO

N/A

December 1, 2024


Summary


Performance

EW Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherEWcash flowmetrics:

Quarterly CFO

N/A

December 1, 2024


Summary


Performance

EW Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherEWcash flowmetrics:

TTM CFO

N/A

December 1, 2024


Summary


Performance

EW TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherEWcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

EW Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

EW Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time

Edwards Lifesciences Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
$351.80 M(-5.3%)
$806.40 M(-6.9%)
Jun 2024
-
$371.50 M(-794.4%)
$866.10 M(+64.0%)
Mar 2024
-
-$53.50 M(-139.2%)
$528.20 M(-41.0%)
Dec 2023
$895.80 M(-26.5%)
$136.60 M(-66.8%)
$895.80 M(-14.0%)
Sep 2023
-
$411.50 M(+1124.7%)
$1.04 B(+10.8%)
Jun 2023
-
$33.60 M(-89.3%)
$940.40 M(-24.1%)
Mar 2023
-
$314.10 M(+11.1%)
$1.24 B(+1.7%)
Dec 2022
$1.22 B(-29.7%)
$282.80 M(-8.7%)
$1.22 B(-6.9%)
Sep 2022
-
$309.90 M(-6.7%)
$1.31 B(-14.5%)
Jun 2022
-
$332.20 M(+13.3%)
$1.53 B(-11.2%)
Mar 2022
-
$293.30 M(-21.5%)
$1.72 B(-0.4%)
Dec 2021
$1.73 B(+64.3%)
$373.60 M(-29.8%)
$1.73 B(-1.5%)
Sep 2021
-
$531.90 M(+1.1%)
$1.76 B(+21.9%)
Jun 2021
-
$526.10 M(+75.1%)
$1.44 B(+25.7%)
Mar 2021
-
$300.50 M(-24.8%)
$1.15 B(+8.9%)
Dec 2020
$1.05 B(-10.9%)
$399.80 M(+85.0%)
$1.05 B(-0.3%)
Sep 2020
-
$216.10 M(-6.6%)
$1.06 B(-17.3%)
Jun 2020
-
$231.30 M(+11.7%)
$1.28 B(-7.9%)
Mar 2020
-
$207.10 M(-48.6%)
$1.39 B(+17.4%)
Dec 2019
$1.18 B(+27.6%)
$402.90 M(-7.9%)
$1.18 B(+10.3%)
Sep 2019
-
$437.30 M(+28.2%)
$1.07 B(+9.7%)
Jun 2019
-
$341.20 M(>+9900.0%)
$977.90 M(+25.9%)
Mar 2019
-
$1.50 M(-99.5%)
$776.90 M(-16.2%)
Dec 2018
$926.70 M(-7.4%)
$292.90 M(-14.4%)
$926.70 M(-7.1%)
Sep 2018
-
$342.30 M(+144.2%)
$997.70 M(+3.3%)
Jun 2018
-
$140.20 M(-7.3%)
$966.20 M(-5.6%)
Mar 2018
-
$151.30 M(-58.4%)
$1.02 B(+2.3%)
Dec 2017
$1.00 B(+42.1%)
$363.90 M(+17.1%)
$1.00 B(+19.4%)
Sep 2017
-
$310.80 M(+57.2%)
$837.90 M(+14.3%)
Jun 2017
-
$197.70 M(+54.1%)
$733.00 M(+1.0%)
Mar 2017
-
$128.30 M(-36.2%)
$725.60 M(+3.0%)
Dec 2016
$704.40 M(+28.1%)
$201.10 M(-2.3%)
$704.40 M(+16.0%)
Sep 2016
-
$205.90 M(+8.2%)
$607.10 M(+0.6%)
Jun 2016
-
$190.30 M(+77.7%)
$603.70 M(+3.5%)
Mar 2016
-
$107.10 M(+3.2%)
$583.50 M(+6.1%)
Dec 2015
$549.70 M(-46.2%)
$103.80 M(-48.7%)
$549.70 M(+2.0%)
Sep 2015
-
$202.50 M(+19.0%)
$539.10 M(+54.6%)
Jun 2015
-
$170.10 M(+132.1%)
$348.80 M(-63.5%)
Mar 2015
-
$73.30 M(-21.4%)
$956.70 M(-6.4%)
Dec 2014
$1.02 B(+116.3%)
$93.20 M(+663.9%)
$1.02 B(-1.7%)
Sep 2014
-
$12.20 M(-98.4%)
$1.04 B(-10.3%)
Jun 2014
-
$778.00 M(+460.1%)
$1.16 B(+127.3%)
Mar 2014
-
$138.90 M(+24.8%)
$510.50 M(+8.0%)
Dec 2013
$472.70 M(+30.5%)
$111.30 M(-15.8%)
$472.70 M(-0.7%)
Sep 2013
-
$132.20 M(+3.2%)
$476.10 M(+0.2%)
Jun 2013
-
$128.10 M(+26.7%)
$475.20 M(-3.8%)
Mar 2013
-
$101.10 M(-11.9%)
$493.90 M(+36.4%)
Dec 2012
$362.10 M
$114.70 M(-12.6%)
$362.10 M(+6.3%)
Sep 2012
-
$131.30 M(-10.6%)
$340.80 M(+4.9%)
Jun 2012
-
$146.80 M(-578.2%)
$324.90 M(+23.7%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$30.70 M(-132.9%)
$262.60 M(-14.8%)
Dec 2011
$308.20 M(+22.6%)
$93.40 M(-19.1%)
$308.20 M(-0.2%)
Sep 2011
-
$115.40 M(+36.6%)
$308.80 M(+6.6%)
Jun 2011
-
$84.50 M(+467.1%)
$289.80 M(+14.4%)
Mar 2011
-
$14.90 M(-84.1%)
$253.30 M(+0.8%)
Dec 2010
$251.40 M(+52.1%)
$94.00 M(-2.5%)
$251.40 M(+12.6%)
Sep 2010
-
$96.40 M(+100.8%)
$223.30 M(+12.6%)
Jun 2010
-
$48.00 M(+269.2%)
$198.40 M(-7.4%)
Mar 2010
-
$13.00 M(-80.3%)
$214.30 M(+29.6%)
Dec 2009
$165.30 M(+7.9%)
$65.90 M(-7.8%)
$165.30 M(-8.1%)
Sep 2009
-
$71.50 M(+11.9%)
$179.90 M(+47.2%)
Jun 2009
-
$63.90 M(-277.5%)
$122.20 M(+40.0%)
Mar 2009
-
-$36.00 M(-144.7%)
$87.30 M(-43.0%)
Dec 2008
$153.20 M(-27.1%)
$80.50 M(+483.3%)
$153.20 M(+2.4%)
Sep 2008
-
$13.80 M(-52.4%)
$149.60 M(-23.4%)
Jun 2008
-
$29.00 M(-3.0%)
$195.20 M(-4.3%)
Mar 2008
-
$29.90 M(-61.1%)
$204.00 M(-2.9%)
Dec 2007
$210.20 M(-8.9%)
$76.90 M(+29.5%)
$210.20 M(+3.4%)
Sep 2007
-
$59.40 M(+57.1%)
$203.30 M(-0.4%)
Jun 2007
-
$37.80 M(+4.7%)
$204.10 M(-0.9%)
Mar 2007
-
$36.10 M(-48.4%)
$205.90 M(-10.8%)
Dec 2006
$230.80 M(+68.7%)
$70.00 M(+16.3%)
$230.80 M(+12.5%)
Sep 2006
-
$60.20 M(+52.0%)
$205.10 M(+11.5%)
Jun 2006
-
$39.60 M(-35.1%)
$183.90 M(+4.0%)
Mar 2006
-
$61.00 M(+37.7%)
$176.90 M(+29.3%)
Dec 2005
$136.80 M(-24.3%)
$44.30 M(+13.6%)
$136.80 M(-4.6%)
Sep 2005
-
$39.00 M(+19.6%)
$143.40 M(-12.9%)
Jun 2005
-
$32.60 M(+56.0%)
$164.70 M(+0.2%)
Mar 2005
-
$20.90 M(-58.9%)
$164.30 M(-9.0%)
Dec 2004
$180.60 M(+27.1%)
$50.90 M(-15.6%)
$180.60 M(-17.1%)
Sep 2004
-
$60.30 M(+87.3%)
$217.90 M(+18.4%)
Jun 2004
-
$32.20 M(-13.4%)
$184.00 M(+4.5%)
Mar 2004
-
$37.20 M(-57.8%)
$176.10 M(+23.9%)
Dec 2003
$142.10 M(+17.8%)
$88.20 M(+234.1%)
$142.10 M(+40.6%)
Sep 2003
-
$26.40 M(+8.6%)
$101.10 M(-4.1%)
Jun 2003
-
$24.30 M(+659.4%)
$105.40 M(-15.5%)
Mar 2003
-
$3.20 M(-93.2%)
$124.70 M(+3.4%)
Dec 2002
$120.60 M(+19.4%)
$47.20 M(+53.7%)
$120.60 M(+0.6%)
Sep 2002
-
$30.70 M(-29.6%)
$119.90 M(+3.4%)
Jun 2002
-
$43.60 M(-4944.4%)
$116.00 M(+8.0%)
Mar 2002
-
-$900.00 K(-101.9%)
$107.40 M(+6.3%)
Dec 2001
$101.00 M(-26.3%)
$46.50 M(+73.5%)
$101.00 M(-2.9%)
Sep 2001
-
$26.80 M(-23.4%)
$104.00 M(-13.1%)
Jun 2001
-
$35.00 M(-579.5%)
$119.70 M(+4.4%)
Mar 2001
-
-$7.30 M(-114.7%)
$114.70 M(-16.3%)
Dec 2000
$137.00 M(-22.2%)
$49.50 M(+16.5%)
$137.00 M(+56.6%)
Sep 2000
-
$42.50 M(+41.7%)
$87.50 M(+94.4%)
Jun 2000
-
$30.00 M(+100.0%)
$45.00 M(+200.0%)
Mar 2000
-
$15.00 M
$15.00 M
Dec 1999
$176.00 M
-
-

FAQ

  • What is the all time high annual CFO for Edwards Lifesciences?
  • What is the all time high quarterly CFO for Edwards Lifesciences?
  • What is the all time high TTM CFO for Edwards Lifesciences?

What is the all time high annual CFO for Edwards Lifesciences?

Edwards Lifesciences all-time high annual cash flow from operations is $1.73 B

What is the all time high quarterly CFO for Edwards Lifesciences?

Edwards Lifesciences all-time high quarterly cash flow from operations is $778.00 M

What is the all time high TTM CFO for Edwards Lifesciences?

Edwards Lifesciences all-time high TTM cash flow from operations is $1.76 B